Conformis Inc
NASDAQ:CFMS
Conformis Inc
NASDAQ:CFMS
Price:
2.26 USD
Market Closed
Updated:
May 5, 2024
Conformis Inc
Revenue
|
Conformis Inc
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Conformis Inc
NASDAQ:CFMS
|
Revenue
$57.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Conformis Inc
Revenue Breakdown
Breakdown by Geography
Conformis Inc
Conformis Inc
|
Total Revenue:
62.1m
USD
|
|
United States:
50.5m
USD
|
|
Non-Us:
4.1m
USD
|
|
Germany:
3.2m
USD
|
Breakdown by Segments
Conformis Inc
Conformis Inc
|
Total Revenue:
62.1m
USD
|
|
Product:
57.8m
USD
|
|
Royalty And Licensing:
4.2m
USD
|
See Also
What is Conformis Inc's Revenue?
Revenue
57.1m
USD
57.1m
USD
Based on the financial report for Jun 30, 2023, Conformis Inc's Revenue amounts to 57.1m USD.
What is Conformis Inc's Revenue growth rate?
Revenue CAGR 5Y
-6%
-6%
Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Conformis Inc have been -8% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
